Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: a randomized controlled trial.
Dena FirouzabadiAmir Reza DehghanianAlireza RezvaniLaleh MahmoudiAbdolrasoul TaleiPublished in: BMC cancer (2021)
This trial was prospectively registered in IRCT.ir ( IRCT2017100136491N1 ). Date of registration: 19 November 2017.